Follow The Filings

RYZ Ryerson

Ryerson earnings company data as of 7:58 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS 0.39 — —
Rev — — —

Insider trades

Open-market buys and sales by RYZ's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RYZ insider trades
  • None no insider bought on the open market
  • $377K sold by 2 insiders outside a trading plan
  • $2.1M sold by 3 insiders under 10b5-1 plans
  1. Molly D Kannan CAO & Corporate Controller
    Planned sale
    $16K 500 shares at $32.00 2% of stake
    Traded Jul 28 Filed Jul 30
  2. Molly D Kannan CAO & Corporate Controller
    Planned sale
    $30K 1,000 shares at $30.00 3.9% of stake
    Traded Jun 11 Filed Jun 15
  3. Mark S. Silver EVP, Chief Legal/Risk Officer
    Sale
    $312K 11,174 shares at $27.91 8.5% of stake
    Traded May 28 Filed Jun 1
  4. Molly D Kannan CAO & Corporate Controller
    Planned sale
    $85K 3,000 shares at $28.42 11% of stake
    Traded May 29 Filed Jun 1
  5. Molly D Kannan CAO & Corporate Controller
    Sale
    $65K 2,500 shares at $26.18 8% of stake
    Traded May 13 Filed May 15
  6. James J Claussen CFO
    Planned sale
    $149K 4,972 shares at $30.00 6.3% of stake
    Traded Feb 3 Filed Feb 4
  7. Edward J. Lehner CEO
    Planned sale
    $1.8M 60,001 shares at $30.06 9.2% of stake
    Traded Jan 21–22 Filed Jan 23

Also filed in the last 12 months, not counted as buying or selling: 26 stock grants, 18 option exercises, and 4 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02,8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 7.01
SCHEDULE 13G —
8-K 5.02,5.03,5.07,9.01
10-Q
8-K 2.02,8.01,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.